Creative Biolabs offers comprehensive mRNA characterization services, specializing in lipid nanoparticle (LNP)-formulated drug analysis to support clients' mRNA drug R&D. Our services encompass detailed characterization of LNP-mRNA formulations, including particle size distribution, zeta potential measurement, encapsulation efficiency assessment, and stability profiling under various conditions. We conduct rigorous in vitro release kinetics studies and in vivo biodistribution analyses to ensure optimal delivery and biocompatibility. Leveraging our innovative LPR technology and decades of expertise, our team of multidisciplinary scientists provides robust data to validate formulation performance, address stability and translation efficiency challenges, and accelerate preclinical development. From early-stage optimization to advanced characterization, our one-stop solutions integrate seamlessly with synthesis and delivery system development, ensuring reliable, high-quality results for applications in oncology, vaccines, and beyond. Contact us to explore how our LNP-formulated drug characterization services can drive your mRNA therapeutics forward.
